Ticker
ABSICompany Name
ABSCI CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Capital Expenditure | Free Cash Flow | Net Cash Flow - Operations |
---|---|---|---|
6/30/2025 | $ -1.65M | $ -74.75M | $ -76.41M |
3/31/2025 | $ -474K | $ -75.9M | $ -76.38M |
12/31/2024 | $ -535K | $ -71.87M | $ -72.4M |
9/30/2024 | $ 28K | $ -70.39M | $ -70.36M |
6/30/2024 | $ 371K | $ -60.36M | $ -59.99M |
3/31/2024 | $ 229K | $ -62.61M | $ -62.38M |
12/31/2023 | $ 606K | $ -65.24M | $ -64.64M |
9/30/2023 | $ 1.14M | $ -69.42M | $ -68.28M |
6/30/2023 | $ 5.72M | $ -82.68M | $ -76.96M |
3/31/2023 | $ 9.41M | $ -89.72M | $ -80.31M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations - CapEx
(=) FCF
FCF for ABSCI CORP is calculated as follows: CF - Operations [ $ -10.97M ] - CapEx [ $ 2.17M ]
(=) FCF [ $ -13.14M ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.3K |
---|---|
min | $ -356.66M |
max | $ 390M |
average | $ 28.8M |
median | $ 464K |
std | $ 117.95M |